Gradient-Based Saliency Maps Are Not Trustworthy Visual Explanations of Automated AI Musculoskeletal Diagnoses

基于梯度的显著性图并非可靠的AI肌肉骨骼自动化诊断视觉解释

阅读:1

Abstract

Saliency maps are popularly used to "explain" decisions made by modern machine learning models, including deep convolutional neural networks (DCNNs). While the resulting heatmaps purportedly indicate important image features, their "trustworthiness," i.e., utility and robustness, has not been evaluated for musculoskeletal imaging. The purpose of this study was to systematically evaluate the trustworthiness of saliency maps used in disease diagnosis on upper extremity X-ray images. The underlying DCNNs were trained using the Stanford MURA dataset. We studied four trustworthiness criteria-(1) localization accuracy of abnormalities, (2) repeatability, (3) reproducibility, and (4) sensitivity to underlying DCNN weights-across six different gradient-based saliency methods (Grad-CAM (GCAM), gradient explanation (GRAD), integrated gradients (IG), Smoothgrad (SG), smooth IG (SIG), and XRAI). Ground-truth was defined by the consensus of three fellowship-trained musculoskeletal radiologists who each placed bounding boxes around abnormalities on a holdout saliency test set. Compared to radiologists, all saliency methods showed inferior localization (AUPRCs: 0.438 (SG)-0.590 (XRAI); average radiologist AUPRC: 0.816), repeatability (IoUs: 0.427 (SG)-0.551 (IG); average radiologist IOU: 0.613), and reproducibility (IoUs: 0.250 (SG)-0.502 (XRAI); average radiologist IOU: 0.613) on abnormalities such as fractures, orthopedic hardware insertions, and arthritis. Five methods (GCAM, GRAD, IG, SG, XRAI) passed the sensitivity test. Ultimately, no saliency method met all four trustworthiness criteria; therefore, we recommend caution and rigorous evaluation of saliency maps prior to their clinical use.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。